Risks and Incidents Involving Simulated Medications
Schroeder, J., O’Neal, C., & Jagneaux, T. (2015). Practically Saline. Journal of investigative medicine high impact case reports, 3(4), 2324709615618980. doi:10.1177/2324709615618980
Torrie J, Cumin D, Sheridan J, Merry AF. Fake and expired medications in simulation-based education: An underappreciated risk to patient safety. BMJ Quality and Safety 2016;25(12):917-20. doi: 10.1136/bmjqs-2015-004793
Strategies and Policy Development
Bajaj K, Minors A, Walker K, Meguerdichian M, Patterson M. “No-Go Considerations” for In Situ Simulation Safety. Simul Healthc. 2018 Apr 4.
Brazil, V., Scott, C., Matulich, J. et al. Developing a simulation safety policy for translational simulation programs in healthcare. Adv Simul 7, 4 (2022).
Brazil V, Purdy E. Simulation Safety Spotlight – a call for Safety briefings in sim. International Clinical Educators Network Royal College of Physicians and Surgeons of Canada. 2019. Accessed February 27, 2022.
Simulation Safety Editorial
Raemer, D, Hannenberg, A, Mullen, A. Simulation Safety First; An Imperative. Simul Healthc. 2018 Dec.
Raemer DB. Ignaz Semmelweis Redux? Simul Healthc. 2014 Jun;9(3):153-5. PMID 24401925
Simulation Safety Editorial : Portuguese Translation
Simulation Safety First Editorial; Translated by Henrique Pierotti Arantes, MD and Carolina Alexio.
Simulation Safety Editorial : Spanish Translation
Simulation Safety First Editorial; Translated by Priscilla Carmiol-Rodríguez, Revisions by Demian Szyld and Jose M. Maestre